Aspira Women's Health Files 8-K

Ticker: AWHL · Form: 8-K · Filed: Sep 13, 2024 · CIK: 926617

Sentiment: neutral

Topics: financial-statements, exhibits, sec-filing

TL;DR

Aspira Women's Health filed an 8-K on 9/13 for a 9/9 event, mostly financial docs.

AI Summary

Aspira Women's Health Inc. filed an 8-K on September 13, 2024, reporting an event on September 9, 2024. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclosures related to the company's financial status. No specific dollar amounts or new material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing signals that Aspira Women's Health Inc. is providing updated financial information or exhibits to the SEC, which could be relevant for investors monitoring the company's financial health.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, not indicating any immediate material adverse events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Aspira Women's Health Inc.?

The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and to provide Financial Statements and Exhibits, with the earliest event reported on September 9, 2024.

When was this 8-K filed with the SEC?

This 8-K was filed as of date September 13, 2024.

What is Aspira Women's Health Inc.'s state of incorporation and IRS Employer Identification Number?

Aspira Women's Health Inc. is incorporated in Delaware and its IRS Employer Identification Number is 33-0595156.

Where is Aspira Women's Health Inc. located?

The company's business address is 12117 Bee Caves Road Building III Suite 100, Austin, Texas 78738.

Does this filing indicate any specific new business developments or financial results?

The provided excerpt of the 8-K filing indicates it is for 'Financial Statements and Exhibits' and Regulation FD Disclosure, but does not detail specific new business developments or financial results within this section.

Filing Stats: 431 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2024-09-13 17:09:35

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 9, 2024, Aspira Women's Health Inc. (the "Company") made a presentation available to investors. A copy of the Slide Deck is furnished as Exhibit 99.1 to this Current Report on Form 8-K filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Slide Deck Presented by Aspira Women's Health Inc. on September 9, 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspira Women's Health Inc. Date: September 13, 2024 By: /s/ Nicole Sandford Nicole Sandford, Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing